Moore Capital Management’s Core Scientific CORZ Stock Holding History

Moore Capital Management’s Portfolio CORZ Stock Details CORZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.19M	Sell	202,620 -352,500	-63%	-$8.3M	0.08%	218
2026 Q1	$8.3M	Buy	555,120 +505,120	+1,010%	+$8.62M	0.17%	99
2025 Q4	$728K	Buy	+50,000	New	+$872K	0.01%	479
2025 Q3	–	Sell	-2,196,921	Closed	-$37.5M	–	640
2025 Q2	$37.5M	Buy	2,196,921 +1,541,921	+235%	+$15.4M	0.47%	51
2025 Q1	$4.74M	Sell	655,000 -985,718	-60%	-$11.2M	0.1%	187
2024 Q4	$23.1M	Buy	1,640,718 +1,065,718	+185%	+$15.7M	0.26%	92
2024 Q3	$6.82M	Sell	575,000 -2,742,161	-83%	-$28.4M	0.13%	186
2024 Q2	$30.8M	Buy	+3,317,161	New	+$16.9M	0.54%	58

Other funds holding CORZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Situational Awareness San Francisco, California $20.2B AUM 612.59% 1-Year Est. Return

JCAM

Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VARA

Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

Moore Capital Management's CORZ Position: Q2 2026 in Review

Moore Capital Management reduced its Core Scientific (CORZ) stake by 63% in Q2 2026, selling an estimated $8.3M and leaving 202,620 shares worth $5.19M. The position accounts for 0.08% of the portfolio, ranked #218.

Moore Capital Management first reported a position in CORZ in Q2 2024 and has held it in 8 quarters since. The position peaked at $37.5M in Q2 2025. 412 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

Moore Capital Management held 202,620 shares of Core Scientific worth $5.19M as of Q2 2026.
Moore Capital Management sold 352,500 Core Scientific shares in Q2 2026, an estimated $8.3M.
Core Scientific made up 0.08% of Moore Capital Management's portfolio in Q2 2026, its #218 holding.
Moore Capital Management first reported a position in Core Scientific in Q2 2024 and has held it in 8 quarters since.
Moore Capital Management's Core Scientific position peaked at $37.5M in Q2 2025.
412 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Moore Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.